Virus sarampion hiperatenuado, Virus parotiditis atenuado, Virus rubeola hiperatenuado, Virus varicela-zoster atenuados cepa oka

Priorix-Tetra Polvo y Disolvente Para Solucion Inyectable

AL MENOS103,0 Dosis infectiva 50% en cultivo celular + AL MENOS104,4 Dosis infectiva 50% en cultivo celular + AL MENOS103,0 Dosis infectiva 50% en cultivo celular + AL MENOS103,3 Unidades formadoras de placa polvo y disolvente para solución inyectableSpainWithdrawnAuthorised 26 Mar 2015

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

Packs

Pack	Code	Status
PRIORIX-TETRA POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE , 10 viales+ 10 ampollas	606604
PRIORIX-TETRA POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE , 100 viales + 100 ampollas	606605
PRIORIX-TETRA POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE , 1 vial + 1 ampolla	705712

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Virus sarampion hiperatenuado, Virus parotiditis atenuado, Virus rubeola hiperatenuado, Virus varicela-zoster atenuados cepa oka

Priorix-Tetra Polvo y Disolvente Para Solucion Inyectable

AL MENOS103,0 Dosis infectiva 50% en cultivo celular + AL MENOS104,4 Dosis infectiva 50% en cultivo celular + AL MENOS103,0 Dosis infectiva 50% en cultivo celular + AL MENOS103,3 Unidades formadoras de placa polvo y disolvente para solución inyectableSpainWithdrawnAuthorised 26 Mar 2015

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

Packs

Pack	Code	Status
PRIORIX-TETRA POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE , 10 viales+ 10 ampollas	606604
PRIORIX-TETRA POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE , 100 viales + 100 ampollas	606605
PRIORIX-TETRA POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE , 1 vial + 1 ampolla	705712

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Virus sarampion hiperatenuado, Virus parotiditis atenuado, Virus rubeola hiperatenuado, Virus varicela-zoster atenuados cepa oka
Strength: AL MENOS103,0 Dosis infectiva 50% en cultivo celular + AL MENOS104,4 Dosis infectiva 50% en cultivo celular + AL MENOS103,0 Dosis infectiva 50% en cultivo celular + AL MENOS103,3 Unidades formadoras de placa
Dosage form: polvo y disolvente para solución inyectable
Route: vía subcutánea
Register: Spain (AEMPS)
Status: Withdrawn
Status in the register: Revocado
Authorised: 26 Mar 2015
Registration: 79634
Marketing authorisation holder: Glaxosmithkline Biologicals
Procedure: National, MRP or DCP
Supply: Uso Hospitalario